Mirador Capital Partners LP Novartis Ag Transaction History

Mirador Capital Partners LP

$529 Million
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	BUY	$94.73 - $105.13 $22,166 - $24,600	234 Added 1.0%	23,702 $2.41 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $7,864 - $8,917	-85 Reduced 0.36%	23,468 $2.37 Million
Q1 2023 Apr 14, 2023	SELL	$80.03 - $92.81 $130,048 - $150,816	-1,625 Reduced 6.45%	23,553 $2.17 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $58,626 - $71,795	-776 Reduced 2.99%	25,178 $2.28 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $21,636 - $25,305	290 Added 1.13%	25,954 $1.97 Million
Q2 2022 Aug 05, 2022	SELL	$80.52 - $93.75 $6,683 - $7,781	-83 Reduced 0.32%	25,664 $2.17 Million
Q1 2022 May 06, 2022	BUY	$80.11 - $90.62 $76,585 - $86,632	956 Added 3.86%	25,747 $2.26 Million
Q4 2021 Feb 02, 2022	BUY	$79.7 - $88.13 $32,437 - $35,868	407 Added 1.67%	24,791 $2.17 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $44,406 - $51,661	543 Added 2.28%	24,384 $1.99 Million
Q2 2021 Jul 27, 2021	BUY	$85.24 - $94.15 $73,732 - $81,439	865 Added 3.76%	23,841 $2.18 Million
Q1 2021 Apr 29, 2021	BUY	$83.5 - $98.47 $111,472 - $131,457	1,335 Added 6.17%	22,976 $1.96 Million
Q4 2020 Jan 20, 2021	BUY	$78.07 - $94.43 $203,060 - $245,612	2,601 Added 13.66%	21,641 $2.04 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $50,926 - $56,420	620 Added 3.37%	19,040 $1.66 Million
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $23,631 - $26,601	292 Added 1.61%	18,420 $1.61 Million
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $149,537 - $209,505	2,116 Added 13.22%	18,128 $1.55 Million
Q4 2019 Jan 17, 2020	BUY	$84.35 - $95.37 $36,186 - $40,913	429 Added 2.75%	16,012 $1.52 Million
Q3 2019 Oct 31, 2019	BUY	$85.54 - $94.26 $21,641 - $23,847	253 Added 1.65%	15,583 $1.35 Million
Q2 2019 Aug 06, 2019	BUY	$75.4 - $92.8 $31,969 - $39,347	424 Added 2.84%	15,330 $1.4 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $1.12 Million - $1.28 Million	14,906 New	14,906 $1.43 Million

Others Institutions Holding NVS

# of Institutions

1,443

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.61M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Account